Target intelligence / Profile preview

Contactin 4 mRNA 3′ untranslated region (CNTN4 mRNA 3′UTR)

Target
CNTN4 mRNA 3′UTR
Molecular classification
Untranslated region, Regulatory RNA element, Messenger RNA component
01

Overview

The 3′ untranslated region (3′UTR) of the Contactin 4 (CNTN4) mRNA is a critical regulatory segment that governs the post-transcriptional expression of the CNTN4 protein. CNTN4 is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein and a member of the immunoglobulin superfamily, playing a vital role in axon guidance, neurite outgrowth, and synaptic plasticity during central nervous system development (PMID: 152330, 38745463). The 3′UTR serves as a hub for microRNA (miRNA) binding, such as miR-148a-3p, which regulates mRNA stability and translation efficiency; dysregulation of this interaction is implicated in inflammatory processes and atherosclerosis (PMID: 34104118). Genetic variations, including point mutations and deletions within or encompassing the CNTN4 3′UTR, are strongly associated with neurodevelopmental and neuropsychiatric conditions, including autism spectrum disorder, 3p deletion syndrome, and spinocerebellar ataxia type 16 (PMID: 16960811, 12851855). While therapeutic strategies targeting the CNTN4 protein with monoclonal antibodies like GENA-104A16 are in clinical trials for oncology, the 3′UTR itself is an emerging target for RNA-based interventions aimed at modulating CNTN4 levels in cardiovascular and neurological diseases.

Other names
CNTN4 3′-UTRContactin-4 3′ untranslated regionBIG-2 mRNA 3′UTRAxonal-associated cell adhesion molecule mRNA 3′UTR
02

Mechanism of action

MicroRNA-mediated translational repression and mRNA degradation via binding to specific response elements within the 3′UTR; monoclonal antibody-mediated inhibition of the downstream protein product.

03

Biological functions

Post-transcriptional regulationmRNA stability regulationTranslational inhibitionAxon guidanceSynaptogenesisNeuronal network formation
04

Disease associations

Autism spectrum disorder3p deletion syndromeSpinocerebellar ataxia type 16AtherosclerosisSolid tumorSchizophrenia
05

Safety considerations

Off-target effects of RNA-based therapeuticsPotential for neurodevelopmental toxicitySystemic inflammatory response to RNA mimicsDisruption of normal axonal pathfinding
06

Interacting drugs

miR-148a-3p mimics

1 more in the full profile.

07

Biomarkers

CNTN4 mRNA expression levelsmiR-148a-3p expression levels3p26.3 deletion status

Beyond the preview

Go deeper on Contactin 4 mRNA 3′ untranslated region (CNTN4 mRNA 3′UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contactin 4 mRNA 3′ untranslated region (CNTN4 mRNA 3′UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call